Tous Actualités
Suivre
Abonner Eli Lilly and Company

Eli Lilly and Company

Global 'Inspired by Diabetes' Creative Expression Competition Deadline Extended Until March 31, 2008

Indianapolis (ots/PRNewswire)

- Global contest seeks expressions of the triumphs and challenges
of living with diabetes through art, essay, poetry, photography and
music
Eli Lilly and Company, the International Diabetes Federation
(IDF), and the International Society for Pediatric and Adolescent
Diabetes (ISPAD) today announced that the entry deadline for
submissions into the global competition will be extended until 31
March 2008. The global Inspired by Diabetes Creative Expression
Competition is a contest asking people with diabetes, as well as
their family and friends, to express how diabetes has impacted their
lives -- and share those stories with others around the world. The
original deadline for entries was 31 January 2008.
The extension of the deadline to 31 March 2008 applies to the
global Inspired by Diabetes Creative Competition. This extension does
not necessarily affect the deadlines of various countries who are
conducting national competitions in support of the global Inspired by
Diabetes Creative Expression Competition.
The Inspired by Diabetes competition seeks expressions of the
challenges and triumphs of the diabetes journey through art, essay,
poetry, photography and music. People with diabetes, and their family
members and friends, are encouraged to enter the contest. Health care
professionals are also invited to enter.
Inspired by Diabetes builds on the theme of IDF's World Diabetes
Day 2007-08, which is dedicated to children and adolescents living
with or at risk of diabetes worldwide. The spirit of the competition
is to bring families and people with diabetes together to raise
awareness of the global burden of diabetes -- and draw particular
attention to people who do not have the resources they need to fight
the disease.
By entering the competition, participants can have a direct impact
on the lives of children with diabetes around the world.
When people enter the contest, they will receive two "blue circle"
diabetes pins, the global symbol for diabetes. For each set of pins
distributed, a dollar will be donated to the International Diabetes
Federation's Life for a Child Program, which provides life-saving
diabetes supplies to more than 500 children in 13 developing
countries. Lilly will also make a separate donation to support the
Life for a Child Program on behalf of entrants to the Inspired by
Diabetes competition.
Contest information
Grand prize winners will be selected for each participant group,
with the winners (excluding health care professionals) receiving a
trip to attend a media briefing and formal exhibition of the winning
entries.
    Participant categories in the Inspired by Diabetes contest are:
    -- Children (age sub-groups 5-6, 7-8, 9-12, 13-17 years old; includes
       children with diabetes or family members or friends under 18)
    -- Adult with diabetes (ages 18 and older)
    -- Family member or friend of a person with diabetes
    -- Health care professional
    Entries may be submitted in the following "format" categories:
    -- Short essay or poem - 500 words or less
    -- Photograph(s) - Up to three prints
    -- Original drawing or painting - no larger than 43cm x 66cm (17" x 26")
    -- Music - Original composition, up to three minutes in length
       (instrumental and lyric)
To learn more about Inspired by Diabetes and how to enter the
Creative Expression Competition, please visit:
www.inspiredbydiabetes.com.
About Unite for Diabetes and the International Diabetes Federation
Unite for Diabetes is a global campaign committed to raising
awareness of diabetes and celebrating the United Nations' World
Diabetes Day Resolution, which establishes the global agenda for the
coming fight against the diabetes pandemic and designates 14 November
as an official UN-observed World Diabetes Day, from 2007.
The Unite for Diabetes and World Diabetes Day campaigns are led by
the International Diabetes Federation (IDF), a worldwide alliance of
over 200 diabetes associations in more than 160 countries. Its
mission is to promote diabetes care, prevention and a cure worldwide.
For more information, visit www.unitefordiabetes.org.
About ISPAD
Globally, diabetes is a disease in evolution affecting more and
more children and adolescents. The INTERNATIONAL SOCIETY for
PEDIATRIC and ADOLESCENT DIABETES (ISPAD) is a professional
organization whose aims are to promote clinical and basic science,
education and advocacy in childhood and adolescent diabetes. The
strength of ISPAD lies in the scientific and clinical expertise in
childhood and adolescent diabetes of its members. ISPAD is the only
international society focusing specifically on all types of childhood
diabetes.
About Lilly Diabetes
Through a long-standing commitment to diabetes care, Lilly
provides patients with breakthrough treatments that enable them to
live longer, healthier and fuller lives. Since 1923, Lilly has been
the industry leader in pioneering therapies to help health care
professionals improve the lives of people with diabetes, and research
continues on innovative medicines to address the unmet needs of
patients.
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a
growing portfolio of first-in-class and best-in-class pharmaceutical
products by applying the latest research from its own worldwide
laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides
answers -- through medicines and information -- for some of the
world's most urgent medical needs.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )
    (Logo: http://www.newscom.com/cgi-bin/prnh/20070621/CLTH001LOGO )

Contact:

Tim Coulom of Lilly, +1-317-655-2998 /Photo: NewsCom:
http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO,
http://www.newscom.com/cgi-bin/prnh/20070621/CLTH001LOGO, AP Archive:
http://photoarchive.ap.org, PRN Photo Desk, photodesk@prnewswire.com

Plus de actualités: Eli Lilly and Company
Plus de actualités: Eli Lilly and Company